49
edits
Changes
→References
1. Collin M, et al., (2015). Haematopoietic and immune defects associated with GATA2 mutation. Br J Haematol 169(2):173-187. PMID 25707267
1. Collin M, et al., (2015). Haematopoietic and immune defects associated with GATA2 mutation. Br J Haematol 169(2):173-187. PMID 25707267
2. Tsai FY, et al., (1994). An early haematopoietic defect in mice lacking the transcription factor GATA-2. Nature 371(6494):221-226. PMID 8078582
2. Tsai FY, et al., (1994). An early haematopoietic defect in mice lacking the transcription factor GATA-2. Nature 371(6494):221-226. PMID 8078582
3. Doré LC, et al., (2012). Chromatin occupancy analysis reveals genome-wide GATA factor switching during hematopoiesis. Blood 119(16):3724-3733. PMID 22383799
3. Doré LC, et al., (2012). Chromatin occupancy analysis reveals genome-wide GATA factor switching during hematopoiesis. Blood 119(16):3724-3733. PMID 22383799
4. May G, et al., (2013). Dynamic analysis of gene expression and genome-wide transcription factor binding during lineage specification of multipotent progenitors. Cell Stem Cell 13(6):754-768. PMID 24120743
4. May G, et al., (2013). Dynamic analysis of gene expression and genome-wide transcription factor binding during lineage specification of multipotent progenitors. Cell Stem Cell 13(6):754-768. PMID 24120743
5. Beck D, et al., (2013). Genome-wide analysis of transcriptional regulators in human HSPCs reveals a densely interconnected network of coding and noncoding genes. Blood 122(14);e12-e22. PMID 23974199
5. Beck D, et al., (2013). Genome-wide analysis of transcriptional regulators in human HSPCs reveals a densely interconnected network of coding and noncoding genes. Blood 122(14);e12-e22. PMID 23974199
6. Vicente C, et al., (2012). Overexpression of GATA2 predicts an adverse prognosis for patients with acute myeloid leukemia and it is associated with distinct molecular abnormalities. Leukemia 26(3):550-554. PMID 21904383
6. Vicente C, et al., (2012). Overexpression of GATA2 predicts an adverse prognosis for patients with acute myeloid leukemia and it is associated with distinct molecular abnormalities. Leukemia 26(3):550-554. PMID 21904383
7. Ayala RM, et al., (2009). Clinical significance of Gata-1, Gata-2, EKLF, and c-MPL expression in acute myeloid leukemia. Am J Hematol 84(20:79-86. PMID 19097174
7. Ayala RM, et al., (2009). Clinical significance of Gata-1, Gata-2, EKLF, and c-MPL expression in acute myeloid leukemia. Am J Hematol 84(20:79-86. PMID 19097174
8. Spinner MA, et al., (2014). GATA2 deficiency: a protein disorder of hematopoiesis, lymphatics, and immunity. Blood 123(6):809-821. PMID 24227816
8. Spinner MA, et al., (2014). GATA2 deficiency: a protein disorder of hematopoiesis, lymphatics, and immunity. Blood 123(6):809-821. PMID 24227816
9. Gröschel S, et al., (2014). A single oncogenic enhancer rearrangement cause concomitant EVI1 and GATA2 reregulation in leukemia. Cell 157(20):369-381. PMID 24703711
9. Gröschel S, et al., (2014). A single oncogenic enhancer rearrangement cause concomitant EVI1 and GATA2 reregulation in leukemia. Cell 157(20):369-381. PMID 24703711
10. Zhang SJ, et al., (2008). Gain-of-function mutation of GATA-2 in acute myeloid transformation of chronic myeloid leukemia. Proc Natl Acad Sci U S A 105(6):2076-2081. PMID 18250304
10. Zhang SJ, et al., (2008). Gain-of-function mutation of GATA-2 in acute myeloid transformation of chronic myeloid leukemia. Proc Natl Acad Sci U S A 105(6):2076-2081. PMID 18250304
11. Zhang SJ, et al., (2009). GATA-2 L359V mutation is exclusively associated with CML progression but no other haematological malignancies and GATA-2 P250A is a novel single nucleotide polymorphism. PMID 19304323
11. Zhang SJ, et al., (2009). GATA-2 L359V mutation is exclusively associated with CML progression but no other haematological malignancies and GATA-2 P250A is a novel single nucleotide polymorphism. PMID 19304323
12. Kumar MS, et al., (2012). The GATA2 transcriptional network is requisite for RAS oncogene-driven non-small cell lung cancer. PMID 22541434
12. Kumar MS, et al., (2012). The GATA2 transcriptional network is requisite for RAS oncogene-driven non-small cell lung cancer. PMID 22541434